1. Wang SX*, Jia MM*, He ZK, Liu XS#. APOBEC3B and APOBEC mutationalsignature as potential predictive markers for immunotherapy response innon-small cell lung cancer. Oncogene. 2018 Apr 26. doi:10.1038/s41388-018-0245-9 (* first author; # correspondence)

2. Chen M, Zhang J, Sampieri K,Clohessy JG, Mendez L, Gonzalez-Billalabeitia E, Liu XS, Lee YR, Fung J, Katon JM, Menon AV, Webster KA, Ng C,Palumbieri MD, Diolombi MS, Breitkopf SB, Teruya-Feldstein J, Signoretti S,Bronson RT, Asara JM, Castillo-Martin M, Cordon-Cardo C, Pandolfi PP. Anaberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.Nat Genet. 2018 Feb;50(2):206-218.

3. Liu XS, Liu Z, Gerarduzzi C, Choi DE, Ganapathy S, Pandolfi PP,Yuan ZM. Somatic human ZBTB7A zinc finger mutations promote cancer progression.Oncogene. 2015 Oct 12. doi: 10.1038/onc.2015.371.

4. Liu XS*, Chandramouly G, Rass E, Guan Y, Wang G, Hobbs RM,Rajendran A, Xie A, Shah JV, Davis AJ, Scully R, Lunardi A*, Pandolfi PP. LRF maintains genomeintegrity by regulating the non-homologous end joining pathway of DNA repair. NatureCommunications. 2015 Oct 8; 6:8325. doi: 10.1038/ncomms9325. (* co-firstauthor)

5. Liu XS, Genet MD, Haines JE, Mehanna EK, Wu S, Chen HI, Chen Y,Qureshi AA, Han J, Chen X, Fisher DE, Pandolfi PP, Yuan ZM. ZBTB7A suppressesmelanoma metastasis by transcriptionally repressing MCAM. Mol Cancer Res. 2015,13(8):1206-17.

6. Liu XS, Little JB, Yuan ZM. Glycolytic metabolism influences globalchromatin structure. Oncotarget. 2015, 6(6):4214-25.

7. Liu XS, Haines JE, Mehanna EK, Genet MD, Ben-Sahra I, Asara JM,Manning BD, Yuan ZM. ZBTB7A acts as a tumor suppressor through thetranscriptional repression of glycolysis. Genes Dev. 2014, 28(17):1917-28. (Highlightedin Nature Reviews Cancer: Isabel Lokody,   NatureReviews Cancer, 14, 649 (2014)) 

8. González-BillalabeitiaE, Seitzer N, Song SJ, Song MS, Patnaik A, LiuXS, Epping MT, Papa A, Hobbs RM, Chen M, Lunardi A, Ng C, Webster KA,Signoretti S, Loda M, Asara JM, Nardella C, Clohessy JG, Cantley LC, PandolfiPP. Vulnerabilities of PTEN-TP53-deficient prostate cancers to compoundPARP-PI3K inhibition. Cancer Discov. 2014, 4(8):896-904.

9. Wang G, Lunardi A,Zhang J, Chen Z, Ala U, Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A,Shaffer DR, Carver B, Liu XS, TaulliR, Kuo WP, Nardella C, Signoretti S, Cordon-Cardo C, Gerald WL, Pandolfi PP. Zbtb7asuppresses prostate cancer through repression of a Sox9-dependent pathway forcellular senescence bypass and tumor invasion. Nat Genet. 2013, 45(7):739-46.

10. Zhang HX, Liu ZX,Sun YP, Zhu J, Lu SY, Liu XS, HuangQH, Xie YY, Zhu HB, Dang SY, Chen HF, Zheng GY, Li YX, Kuang Y, Fei J, Chen SJ,Chen Z, Wang ZG. Rig-I regulates NF-κB activity through binding to Nf-κb13'-UTR mRNA. Proc Natl Acad Sci U S A. 2013, 110(16):6459-64.

11. Liu XS*, Zhao XD*, Wang X*, Yao YX, Zhang LL, Shu RZ, Ren WH,Huang Y, Huang L, Gu MM, Kuang Y, Wang L, Lu SY, Chi J, Fen JS, Wang YF, Fei J,Dai W, Wang ZG. Germinal Cell Aplasia in Kif18aMutant Male Mice Due to Impaired ChromosomeCongression and Dysregulated BubR1 and CENP-E. Genes Cancer. 2010, 1(1):26-39. (*co-first author) (Highlighted as cover story)

12. Shu RZ, Zhang F, Liu XS, Li CL, Wang L, Tai YL, Wu XL,Yang X, Liao XD, Jin Y, Gu MM, Huang L, Pang XF, Wang ZG. Target deletion ofthe cytoskeleton-associated protein palladin does not impair neurite outgrowthin mice. PLoS One. 2009, 4(9):e6916.

13. Wu XL, Gu MM, HuangL, Liu XS, Zhang HX, Ding XY, Xu JQ,Cui B, Wang L, Lu SY, Chen XY, Zhang HG, Huang W, Yuan WT, Yang JM, Gu Q, FeiJ, Chen Z, Yuan ZM, Wang ZG. Multiple synostoses syndrome is due to a missensemutation in exon 2 of FGF9 gene. Am J Hum Genet. 2009, 85(1):53-63.

14. Wang Y, Zhang HX,Sun YP, Liu ZX, Liu XS, Wang L, LuSY, Kong H, Liu QL, Li XH, Lu ZY, Chen SJ, Chen Z, Bao SS, Dai W, Wang ZG. Rig-I-/-mice develop colitis associated with downregulation of G alpha i2. Cell Res.2007, 17(10):858-68.

15. Liu XS, Li XH, Wang Y, Shu RZ, Wang L, Lu SY, Kong H, Jin YE,Zhang LJ, Fei J, Chen SJ, Chen Z, Gu MM, Lu ZY, Wang ZG. Disruption of palladinleads to defects in definitive erythropoiesis by interfering witherythroblastic island formation in mouse fetal liver. Blood. 2007, 110(3):870-76.

16. Liu XS, Luo HJ, Yang H, Wang L, Kong H,Jin YE, Wang F, Gu MM, Chen Z, Lu ZY, Wang ZG. Palladin regulates cell andextracellular matrix interaction through maintaining normal actin cytoskeletonarchitecture and stabilizing beta1-integrin. J Cell Biochem. 2007, 100(5):1288-300.

17. Luo H*, Liu X*, Wang F, Huang Q, Shen S, WangL, Xu G, Sun X, Kong H, Gu M, Chen S, Chen Z, Wang Z. Disruption of palladinresults in neural tube closure defects in mice. Mol Cell Neurosci. 2005, 29(4):507-15.(* co-first author)